Summary:
Orange County Research Center is conducting a PHASE III Randomized, double-blind, multicenter study to evaluate the efficacy and safety of Ertugliflozin in patients with Type 2 Diabetes Mellitus and inadequate glycemic control on Metformin.
Qualified Participants Must:
• Be 18 years of age and older
•
Have a diagnosis of type 2 Diabetes
•
Be taking Metformin with an A1C of 7.0% and higher
Qualified Participants May Receive:
Compensation for time and travel, up to $1000.00. ($50 per visit)